Unit I General Pharmacology

See discussions, stats, and author profiles for this publication at: https://www.researchgate.
net/publication/325103012
UNIT-I: General Pharmacology
Presentation · May 2018

DOI: 10.13140/RG.2.2.16659.17443
CITATIONS READS
0 202,182
1 author:
Dr Sumanta Mondal
GITAM (Deemed to be University)
332 PUBLICATIONS 991 CITATIONS
SEE PROFILE
All content following this page was uploaded by Dr Sumanta Mondal on 12 May 2018.
The user has requested enhancement of the downloaded file.

UNIT – I: General Pharmacology
UNIT - I
General Pharmacology
a) Introduction, definition and scope of Pharmacology
b) Routes of administration of drugs
c) Pharmacokinetics (Absorption, Distribution, Metabolism and Elimination)
d) Pharmacodynamic-receptor and non-receptor mediated mechanism of drug, receptor drug interactions and adverse
drug reactions
e) Factors modifying drug effects
(A) Introduction, definition and scope of Pharmacology

 DEFINITION OF PHARMACOLOGY
 Pharmacology is the study of the therapeutic value and/or potential toxicity of chemical agents on biological
systems.
 It targets every aspect of the mechanisms for the chemical actions of both traditional and novel therapeutic
agents.
 Two important and interrelated areas are: pharmacodynamic and pharmacokinetics.
i. Pharmacodynamic (what drug does with the body) are the study of the molecular, biochemical, and
physiological effects of drugs on cellular systems and their mechanisms of action.
ii. Pharmacokinetics (what body does with the drug) deals with the absorption, distribution, and excretion
of drugs.
 SCOPE OF PHARMACOLOGY
A. History
 It is of intellectual interest to know how drugs are discovered and developed. Often in the past, this was
based on folklore or intelligent observation (e.g. digitalis leaf, penicillin). Nowadays, new drugs are
mostly developed by the organic chemist working with a pharmacologist, increasingly from basic
knowledge about key molecular targets. Usually some sort of biological screen is used to select among
organic molecules for optimum pharmacological activity.
1. Francois Magendie (1783-1855), a French physiologist laid down the dictum "Facts and facts alone are
the basis of science." Experimental procedures with animals are the testing grounds for determination of
drug action.
2. Claude Bernard (1813-1878), investigated the plant extract curare and proposed a site of action for this
agent.
3. Rudolph Buchheim (1820-1879). In 1847 Buchheim established the first laboratory devoted to
experimental pharmacology in the basement of his home in Dorpat which is known as the cradle of
experimental pharmacology.
4. Oswald Schmiedeberg (1838-1921). In 1872 set up an institute of pharmacology in Strasbourg, France
(Germany at that time) which became a mecca for students who were interest in pharmacological
problems.
5. J.N. Langley (1852-1925 and Sir Henry Dale (1875-1968) pioneered pharmacology in England, taking a
physiological approach.
6. John J. Abel (1857-1938) established the first chair of pharmacology in the U.S.A. (U. Michigan, 1891) after
training in Germany. Able went to Johns Hopkins in 1893, and trained many U.S. pharmacologists. He is
known as "The Father of American Pharmacology".
7. The Second World War was the impetus for accelerated research in pharmacology (the war time
antimalarial program) in the U.S., and introduced strong analytical and synthetic chemical approaches.
Lecture Notes_Dr. Sumanta Mondal_ PHARMACOLOGY – I (PPH 206)_B.Pharm-VI Sem_GITAM University. Page | 1
B. Chemistry
 Chemical structures of drugs can provide information about mechanism of action, pharmacokinetics,
stability, and metabolic fate.
1. Structure-Activity Relationship: A modification of the chemical structure of a drug may accentuate or
diminish its pharmacological effects, often providing clues as to the mechanism of action. A picture of the
biological reactive site (the receptor) can be developed in such studies. Also, drugs are metabolized by
body systems, which may convert the parent drug to a more active or a less active form. The drug structure
can be modified to enhance or diminish the rate of metabolic conversion.
2. Sites of Action: The organ or cellular target of drug action.
3. Drug Receptors: Macromolecules in cells or cell membranes with which drugs interact to exert their
effects. Usually the interacting forces are reversible ionic and Van der Waals bonds of relatively low energy,
but sometimes covalent bonds are formed (e.g. organophosphate insecticides).
C. Pharmacodynamic
 The effect of the drug on the body. Pharmaco-dynamics is the study of the relationship of drug
concentration and the biologic effect (physiological or biochemical).
 For most drugs it is necessary to know the site of action and mechanism of action at the level of the
organ, functional system, or tissue. For example, the drug effect may be localized to the brain, the
neuromuscular junction, the heart, the kidney, etc. Often the mechanism of action can be described in
biochemical or molecular terms. Most drugs exert effects on several organs or tissues, and have
unwanted as well as therapeutic effects. There is a dose-response relationship for wanted and
unwanted (toxic) effects.
 Patient factors affect drug responses - age, weight, sex, diet, race, genetic factors, disease states, trauma,
concurrent drugs, etc.
D. Pharmacokinetics
 The effect of the body on the drug. To produce its characteristic effects, a drug must be present in
appropriate concentrations at its sites of action. Thus, it is important to know the interrelationship of
the absorption, distribution, binding, biotransformation, and excretion of a drug and its concentration
at its locus of action.
1. Absorption (oral or parenteral): A drug must be absorbed and achieve adequate concentration at its site of
action in order to produce its biological effects. Thus, when a drug is applied to a body surface (e.g., G.I.
tract, skin, etc.), its rate of absorption will determine the time for its maximal concentration in plasma and
at the receptor to produce its peak effect.
2. Distribution: The blood, total body water, extracellular, lymphatic and cerebrospinal fluids are involved in
drug movement throughout the body. Depending upon its chemical and physical properties, the drug may
be bound to plasma proteins or dissolved in body fat, delaying its progress to its sites of action or excretory
mechanism.
3. Metabolism: This is how certain drugs are handled by the body in preparation for their elimination and
includes the fate of drugs-biotransformation (e.g., hydrolysis, conjugation, oxidation-reduction).
4. Excretion: The kidney is the most important organ for drug excretion but the liver, lung and skin are also
involved in drug elimination. Drugs excreted in feces are mostly derived from unabsorbed, orally ingested
drugs or from metabolites excreted in the bile and not reabsorbed by the intestine. The physical and
chemical properties, especially the degree of ionization of the drug, are important in the rate of excretion.
5. Biological Factors Modifying Pharmacokinetic Aspects: Normal variations occur in population
pharmacokinetic constants (absorption rates, elimination rates). Other factors include age, weight, obesity,
edema, concurrent diseases, other drugs (various interactions including effects on protein binding or
metabolic rate), diet, dose interval and route of administration, genetic variations in elimination rate.
E. Clinical Pharmacology and Therapeutics

1. Indications and Therapeutic Uses: Emphasis is placed on the therapeutic use of drugs for the treatment of
disease in clinical pharmacology, internal medicine and therapeutics. There are specific clinic disorders or
disease entities for which a given drug may be prescribed and the physician must weigh the potential
benefit of drug use against the risks of adverse effects.
2. Contraindications and Factors (e.g., liver disease) May Modify Drug Action: Where detoxification of the
drug by the liver is important. It is important to know that the presence of disease or organ pathology may
influence the actions of a drug. Conditions such as age, pregnancy, concomitant administration of other
drugs and disease may alter the patient's response to a given drug.
3. Posology: It is an archaic term describing dosage regimens. Consideration of dosage schedules is a part of
pharmacokinetics.
4. Bioavailability: The fraction of drug administered which is actually absorbed and reaches the systemic
circulation following oral dosing. Preparations of the same drug by different manufacturers may have a
different bioavailability.
5. Prescription writing: It is important that the physician write clear, error-free directions for the drug
provider (pharmacist) and for the patient. Physicians must guard against prescribing too many drugs, or
preparations of little value. Drugs of unproven clinical value should be avoided, as well as potentially toxic
agents if drugs equally effective but less dangerous are available. Risk-benefit and cost-benefit should be
considered. Drugs may be prescribed by generic name, since often a less expensive drug product can be
obtained in this way. A particular manufacturer may be specified if the physician has reason to believe a
better or more reliable preparation is available from that manufacturer.
6. Drug Nomenclature: In addition to its formal chemical name, a new drug is usually assigned a code name
by the pharmaceutical manufacturer. If the drug appears promising and the manufacturer wishes to place it
on the market, a United States Adopted Name (USAN) is selected by the USAN Council which is sponsored
by:
i. The American Medical Association
ii. The American Pharmaceutical Association
iii. The United States Pharmacopoeial Convention
F. Toxicology
 The aspect of Toxicology deals with the adverse effects of chemical agents.
 Toxicology is concerned not only with drugs used in therapy but also with the other chemicals that may
be responsible for household, environmental or industrial intoxication.
1. Forensic Toxicology: Addresses medicolegal aspects of the use of chemicals that are harmful to animals or
man. Analytical chemistry and fundamental toxicological principles are hybridized to underlie this aspect
of toxicology. Nonetheless accidental poisoning with drugs is a health problem of major significance. More
than 1/4 of the fatalities and about 1/2 of all poisonings occur in children under 5 years of age. All common
household articles that are poisonous should be made unavailable to children, and poisonous rodenticides
and insecticides should not be placed in the home.
2. Clinical Toxicology: Focuses on toxic events that are caused by or are uniquely associated with drugs or
other chemicals
G. Pharmacovigilence
 The area of Pharmacovigilence that focuses on the effects of drugs on patient safety.
 It involves the characterization, detection, and understanding of adverse events associated with drug
administration, including adverse drug reactions, toxicities, and side effects that arise as a consequence
of the short- or long-term use of drugs.
 Adverse drug reactions, including drug-drug interactions, are estimated to be a major cause of
mortality of inpatients and also lead to significant increases in duration of hospitalization. No drug is
free of toxic effects. Some untoward effects of drugs are trivial, but others are serious and may be fatal.
Side effects often are predictable from knowledge of the pharmacology of a particular drug.
 Examples of chemicals or drug-induced toxicities are given below:
1. Allergic reactions: The number of serious allergic reactions to drugs involving antigen-antibody reactions
is low but when they occur the physician must have sufficient knowledge to manage these problems.
2. Blood dyscrasias: These are very serious and sometimes fatal complications of drug therapy. They
include: agranulocytosis, aplastic anemia, hemolytic anemia, thrombocytopenia and defects in clotting
factors.
3. Hepatotoxicity and nephrotoxicity: Because many chemicals and drugs are eliminated and metabolized
by the liver and kidney, damage to these organs is seen commonly.
4. Teratogenic effects: The thalidomide tragedy dramatically emphasized that drugs may adversely
influence fetal development.
5. Behavioral toxicity: This is a term used to describe suppression of normal anxiety, reduction in
motivation, impairment of memory and learning, distortion of judgement, impairment of reflexes, adverse
effects on mood, etc.
6. Drug dependence and drug abuse: The repeated administration of some chemicals may lead to drug
dependence. Drugs likely to be abused and upon which drug dependence may develop are the various
psychopharmacological agents such as opiates, barbiturates, amphetamines, nicotine and ethanol.
Dependence on tobacco (nicotine) is also well known.
7. Carcinogenesis: Carcinogenesis is a delayed type of toxicity with a latency of many years.
8. Pharmacogenetic toxicities: Certain genetically-predisposed individuals have a markedly toxic reaction
to certain otherwise safe drugs. Examples are prolonged apnea after succinylcholine, or malignant
hyperthermia associated with anesthetics.
(B) Routes of administration of drugs
 Definition
- A route of administration in pharmacology and toxicology is the path by which a drug, fluid, poison, or other
substance is taken into the body.
- Most of the drugs can be administered by different routes. Drug- and patient-related factors determine the
selection of routes for drug administration. The factors are:
1. Characteristics of the drug.
2. Emergency/routine use.
3. Site of action of the drug—local or systemic.
4. Condition of the patient (unconscious, vomiting, diarrhoea).
5. Age of the patient.
6. Effect of gastric pH, digestive enzymes and first-pass metabolism.
7. Patient’s/doctor’s choice (sometimes).
- Before consider the various routes of drug administration, let study of how drugs move within the body:-
(Schematic diagram showing the various pharmacokinetic processes following administration of a drug. D drug, P protein, R receptor)
1. LOCAL ROUTES
- It is the simplest mode of administration of a drug at the site where the desired action is required. Systemic side
effects are minimal.
i. Topical: Drug is applied to the skin or mucous membrane at various sites for local action.
a) Oral cavity: As a suspension, e.g. nystatin; as a troche, e.g. clotrimazole (for oral candidiasis); as a
cream, e.g. acyclovir (for herpes labialis); as ointment and jelly, e.g. 5% lignocaine hydrochloride (for
topical anaesthesia); as a spray, e.g. 10% lignocaine hydrochloride (for topical anaesthesia).
b) GI tract: As tablet that is not absorbed, e.g. neomycin (for sterilization of gut before surgery).
c) Rectum, Vaginal and anal canal:
 As an enema (administration of drug into the rectum in liquid form):
- Evacuant enema (for evacuation of bowel): For example, soap water enema—soap acts as a lubricant
and water stimulates the rectum.
- Retention enema: For example, methylprednisolone in ulcerative colitis.
 As a suppository (administration of the drug in a solid form into the rectum), e.g. bisacodyl—
for evacuation of bowels.
 Advantages
- Used in children.
- Little first pass effect.
- Can be given in vomiting.
- Can be given in unconscious patient.
- Higher therapeutic concentrations of drug are achieved rapidly in rectum.
- For rapid evacuation of bowel, usually during gut sterilization before any surgical or radiological
procedure.
 Disadvantages
- Inconvenient.
- Drug absorption is slow and erratic.
- Irritation or inflammation of rectal mucosa can occur.
d) Eye, ear and nose: As drops, ointments and sprays (for infection, allergic conditions, etc.), e.g.
gentamicin eye/ear drops.
e) Bronchi: As inhalation, e.g. salbutamol (for bronchial asthma and chronic obstructive pulmonary
disease). Gases, volatile liquids and solids (in the form of finely divided powders) are inhaled for
systemic and local effects. Inhalation of solids is called insufflation.
 Advantages
- Rapid absorption of the drug due to large surface area.
- First pass effect is avoided.
- Rapid local effects.
 Disadvantages
- Only few drugs can be administered.
- May produce irritation of pulmonary mucosa.
- Inconvenient procedure.
- Chances of cardiotoxicity.
f) Skin: As ointment, cream, lotion or powder, e.g. clotrimazole (antifungal) for cutaneous candidiasis.
g) Transdermal: Transdermal patches can provide prolonged or controlled (iontophoresis) drug
delivery. Systemic absorption (Transdermal) is better with low dose, low MWt, lipid soluble drugs
ii. Intra-arterial route: This route is rarely employed. It is mainly used during diagnostic studies such as
coronary angiography and for the administration of some anticancer drugs, e.g. for treatment of malignancy
involving limbs.
iii. Administration of the drug into some deep tissues by injection, e.g. administration of triamcinolone
directly into the joint space in rheumatoid arthritis.
- Typical Plot of Concentration versus Time after Topical Administration
- Typical Plot of Concentration versus Time after Inhalation Administration
- Typical Plot of Concentration versus Time after Rectal Administration
2. a) Systemic Routes (Enteral)
 Drugs administered by this route enter blood and produce systemic effects. Enteral Routes It includes (i) Oral
route, (ii) Buccal or Sublingual route and (iii) Rectal route.
i. ORAL ROUTE
 It is the most common and acceptable route for drug administration. Dosage forms are tablet, capsule, syrup,
mixture, etc., e.g., paracetamol tablet for fever, omeprazole capsule for peptic ulcer are given orally.
 Advantages:
- Convenient - portable, safe, no pain, can be self-administered.
- Cheap - no need to sterilize (but must be hygienic of course)
- Variety of dosage forms available - fast release tablets, capsules, enteric coated, layered tablets, slow
release, suspensions, mixtures
- Convenient for repeated and prolonged use.
 Disadvantages:
- Sometimes inefficient :- high dose or low solubility drugs may suffer poor availability, only part of the dose
may be absorbed. Griseofulvin was reformulated to include the drug as a micronized powder. The
recommended dose at that time was decreased by a factor of two because of the improved bioavailability.
- First-pass effect :- drugs absorbed orally are transported to the general circulation via the liver. Thus drugs
which are extensively metabolized will be metabolized in the liver during absorption. e.g. the propranolol
oral dose is somewhat higher than the IV, the same is true for morphine. Both these drugs and many others
are extensively metabolized in the liver.
First Pass Effect

- Food :- Food and G-I motility can effect drug absorption. Often patient instructions include a direction to
take with food or take on an empty stomach. Absorption is slower with food for tetracyclines and
penicillins, etc. However, for propranolol bioavailability is higher after food, and for griseofulvin
absorption is higher after a fatty meal.
- Local effect :- Antibiotics may kill normal gut flora and allow overgrowth of fungal varieties. Thus,
antifungal agent may be included with an antibiotic.
- Unconscious patient :- Patient must be able to swallow solid dosage forms. Liquids may be given by tube.
 Typical Plot of Concentration versus Time after Oral Administration Fast and Slow Release Dosage Forms
ii. BUCCAL and SUBLINGUAL ROUTE (SL)

 Some drugs are taken as smaller tablets which are held in the mouth or under the tongue.
 These are buccal or sublingual dosage forms.
 Buccal tablets are often harder tablets [4 hour disintegration time], designed to dissolve slowly.
Nitroglycerin, as a softer sublingual tablet [2 min disintegration time], may be used for the rapid relief of
angina.
 This Route of administration is also used for some steroids such as testosterone and oxytocin. Nicotine
containing chewing gum may be used for cigarette smoking replacement.
 Advantages:
- Quick onset of action.
- Action can be terminated by spitting out the tablet.
- Bypasses first-pass metabolism.
- Self-administration is possible.
 Disadvantages
- It is not suitable for bitter tasting and unpalatable drug.
- It is not suitable for Irritant and lipid-insoluble drugs.
- cannot give to unconscious patient.
- Large quantities cannot be given.
- Cannot be given in severe vomiting.
 Typical Plot of Concentration versus Time after Buccal Administration
 Typical Plot of Concentration versus Time after Sublingual Administration
iii. RECTAL ROUTE

 Drugs can be given in the form of solid or liquid.
- Suppository: It can be used for local (topical) effect as well as systemic effect, e.g. indomethacin
for rheumatoid arthritis.
- Enema: Retention enema can be used for local effect as well as systemic effect. The drug is
absorbed through rectal mucous membrane and produces systemic effect, e.g. diazepam for status
epilepticus in children.
 Advantages
- Used in children.
- Little first pass effect.
- Can be given in vomiting.
- Can be given in unconscious patient.
- Higher therapeutic concentrations of drug are achieved rapidly in rectum.
- For rapid evacuation of bowel, usually during gut sterilization before any surgical or radiological
procedure.
 Disadvantages
- Inconvenient, not well accepted. May be some discomfort
- Drug absorption is slow and erratic.
- Irritation or inflammation of rectal mucosa can occur
 Typical Plot of Concentration versus Time after Rectal Administration
2. b) Systemic Routes (Parenteral)

 Routes of administration other than enteral route are called parenteral routes.
 Advantages of parenteral routes
- Onset of action of drugs is faster; hence it is suitable for emergency.
- Useful in:
- Unconscious patient.
- Uncooperative and unreliable patients.
- Patients with vomiting and diarrhoea.
- It is suitable for:
- Irritant drugs.
- Drugs with high first-pass metabolism.
- Drugs not absorbed orally.
- Drugs destroyed by digestive juices.
 Disadvantages of parenteral routes
- Require aseptic conditions.
- Preparations should be sterile and is expensive.
- Requires invasive techniques that are painful.
- Cannot be usually self-administered.
- Can cause local tissue injury to nerves, vessels, etc.
i. INTRAVENOUS (IV)
 Drugs may be given into a peripheral vein over 1 to 2 minutes or longer by infusion, or Drugs are injected
directly into the blood stream through a vein.
 Drugs are administered as:
a) Bolus: Single, relatively large dose of a drug injected rapidly or slowly as a single unit into a vein. For
example, i.v. ranitidine in bleeding peptic ulcer.
b) Slow intravenous injection: For example, i.v. morphine in myocardial infarction.
c) Intravenous infusion: For example, dopamine infusion in cardiogenic shock; mannitol infusion in
cerebral oedema; fluids infused intravenously in dehydration.
 Advantages
- Bioavailability is 100%.
- Quick onset of action; therefore, it is the route of choice in emergency, e.g. intravenous diazepam to control
convulsions in status epilepticus.
- Large volume of fluid can be administered, e.g. intravenous fl uids in patients with severe dehydration.
- Highly irritant drugs, e.g. anticancer drugs can be given because they get diluted in blood.
- Hypertonic solution can be infused by intravenous route, e.g. 20% mannitol in cerebral oedema.
- By i.v. infusion, a constant plasma level of the drug can be maintained, e.g. dopamine infusion in cardiogenic
shock.
 Disadvantages
- Once the drug is injected, its action cannot be halted.
- Local irritation may cause phlebitis.
- Self-medication is not possible.
- Strict aseptic conditions are needed.
- Extravasation of some drugs can cause injury, necrosis and sloughing of tissues.
- Depot preparations cannot be given by i.v. route.
 Precautions
- Drug should usually be injected slowly.
- Before injecting, make sure that the tip of the needle is in the vein.
 Typical Plot of Concentration versus Time during an IV Infusion Administration
 Typical Plot of Concentration versus Time during an IV Bolus Administration
ii. SUBCUTANEOUS (s.c.) ROUTE

 The drug is injected into the subcutaneous tissues of the thigh, abdomen and arm, e.g. adrenaline, insulin, etc.
 Advantages:
- Actions of the drugs are sustained and uniform.
- Drugs can be given in presence of vomiting and diarrhea.
- Drugs can be given to unconscious patients.
- Drugs that are not absorbed from G.I.T can be given.
- Self-administration is possible (e.g. insulin).
- Depot preparations can be inserted into the subcutaneous tissue, e.g. norplant for contraception.
 Disadvantages
- Only non-irritant drugs can be given otherwise severe irritation, pain and necrosis of subcutaneous
tissues can occur.
- Absorption of the drugs is slow than I/M injection.
- Expensive.
- Danger of infection, if proper sterilization techniques are not used.
- Large volumes of drug cannot be given.
 Typical Plot of Concentration versus Time during subcutaneous Administration
iii. INTRAMUSCULAR (i.m) ROUTE

 The drug is injected deep in the belly of a large skeletal muscle. The muscles that are usually used are detoid,
triceps, Gluteus,. Maximus, rectus, femurs depending on the specie of animal.
 The muscle is less richly supplied with sensory nerves, hence injecting a drug 1m is less painful.
 Absorption of drug from gluteal region is slow especially in females due to high fat deposition.
 Deep intramuscular injections are given at upper outer quadrant of buttock to prevent the injury to major
nerves.
 Deep I/M injections are less painful than I/M injections on arm due to high fat content.
 Intramuscular injections are given at an angle of 90 degrees.
 Advantages
- Rate of absorption is uniform.
- Rapid onset of action.
- Irritant substances can be given.
- Drugs can be given to unconscious patients.
- Accuracy of dosage is ensured.
- Useful in emergency situations.
- Drugs producing gastric irritation can be given.
- Drugs that are not absorbed from G.I.T can be given.
 Disadvantages
- Small quantities up to 10 ml of the drug can be given at a time.
- Local pain and abscess formation.
- Technical person is needed, self-administration is difficult.
- Expensive.
- Danger of infection, if proper sterilization techniques are not used.
- Chances of nerve damage.
 Typical Plot of Concentration versus Time during Intramuscular Administration
iv. INTRATHECAL ROUTE

 Drug is injected into the subarachnoid space (spinal anaesthetics, e.g. lignocaine; antibiotics, e.g. amphotericin B,
etc.).
v. INTRA-ARTICULAR ROUTE
 Drug is injected directly into the joint space, e.g. hydrocortisone injection for rheumatoid arthritis. Strict aseptic
precautions should be taken. Repeated administration may cause damage to the articular cartilage.
v. TRANSDERMAL ROUTE
 The drug is administered in the form of a patch or ointment that delivers the drug into the circulation for
systemic effect.
 For example, scopolamine patch for sialorrhoea and motion sickness, nitroglycerin patch/ointment for angina,
oestrogen patch for hormone replacement therapy (HRT).
Transdermal drug-delivery system.
vi. INTRAPERITONEAL ROUTE

 Indication: Colon and Ovarian
 Peritoneal space has much surface area; may not be reached by IV chemo
 Catheters used: implanted port
 Chemotherapy agents used: Cisplatin, Taxol
 Advantages: less systemic side effects
 Disadvantages: infection, pain.
vii. INTRAPLEURAL
 Seeding of pleura
 Used as sclerosing agent to stop pleural effusions
 Injected by physician into chest tube and clamped. Patient changes position 15 min for 1 hour
 Chemotherapy agents used: Bleomycin, Adriamycin, Talc slurry
 Side effects: severe pain
View publication stats

Unit I General Pharmacology

Uploaded by

Copyright:

Available Formats

Unit I General Pharmacology

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Unit I General Pharmacology

Uploaded by

Copyright:

Available Formats

See discussions, stats, and author profiles for this publication at: https://www.researchgate.

UNIT-I: General Pharmacology

Presentation · May 2018

The user has requested enhancement of the downloaded file.

(A) Introduction, definition and scope of Pharmacology

E. Clinical Pharmacology and Therapeutics

- Typical Plot of Concentration versus Time after Inhalation Administration

- Typical Plot of Concentration versus Time after Rectal Administration

First Pass Effect

ii. BUCCAL and SUBLINGUAL ROUTE (SL)

 Typical Plot of Concentration versus Time after Sublingual Administration

iii. RECTAL ROUTE

2. b) Systemic Routes (Parenteral)

 Typical Plot of Concentration versus Time during an IV Bolus Administration

ii. SUBCUTANEOUS (s.c.) ROUTE

iii. INTRAMUSCULAR (i.m) ROUTE

iv. INTRATHECAL ROUTE

Transdermal drug-delivery system.

vi. INTRAPERITONEAL ROUTE

View publication stats

You might also like